FindTrial
Sign In

The risk factors and prediction model for liver failure in patients with hepatitis E

The risk factors and prediction model for liver failure in patients with hepatitis E

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117570
Enrollment
Unknown
Registered
2026-01-26
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis E

Interventions

Observation group:N/A

Sponsors

Beijing Youan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Positive for Hepatitis E virus serological markers: HEV-IgM positive or HEV RNA positive; 2.Abnormal liver function: Elevated levels of any one of ALT, AST, or TBil;

Exclusion criteria

Exclusion criteria: 1.Immunosuppressed patients (e.g., post-liver transplant recipients, those on long-term immunosuppressants); 2.Patients with incomplete baseline characteristics and laboratory test clinical data; 3.Patients with unknown disease prognosis or outcome;

Design outcomes

Primary

MeasureTime frame
Adverse outcome (liver failure);Discriminability;Accuracy;—

Countries

China

Contacts

Public ContactHuaibin Zou

Beijing Youan Hospital, Capital Medical University

zhbin03@126.com+86 10 8399 7156

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026